Sinotherapeutics Inc.’s Net Profit Dropped 34.3% in First Three Quarters of 2023

Sinotherapeutics Inc. (上海宣泰医药科技股份有限公司) (688247.SH) reported a net profit of 44.1 million yuan in the first three quarters of 2023, down 34.3% year-on-year.

Meanwhile, the company posted 213.4 million yuan in revenue, up 14.2% year-on-year.

At the end of the reporting period, it had 1.4 billion yuan in total assets and 159.7 million yuan in total liabilities, with a liability-to-asset ratio of 11.8%.